From July 1, 2021 to September 30, 2021, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 3,250,193 shares, representing 3.23% for $12 million under the buyback announced on November 4, 2020.
BioDelivery Sciences International, Inc.
Equities
BDSI
US09060J1060
Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
+38.59% | 727B | |
+30.31% | 592B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.21% | 238B | |
+7.02% | 204B | |
-5.52% | 203B | |
-1.70% | 160B |